| Global Challenge of Multidrug-Resistant Acinetobacter baumannii F Perez, AM Hujer, KM Hujer, BK Decker, PN Rather, RA Bonomo Antimicrobial agents and chemotherapy 51 (10), 3471-3484, 2007 | 1908 | 2007 |
| Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clinical Infectious Diseases 66 (2), 163-171, 2018 | 647 | 2018 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 521 | 2017 |
| The continuing challenge of ESBLs F Perez, A Endimiani, KM Hujer, RA Bonomo Current opinion in pharmacology 7 (5), 459-469, 2007 | 504 | 2007 |
| Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae? S Marshall, AM Hujer, LJ Rojas, KM Papp-Wallace, RM Humphries, ... Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02243-16, 2017 | 305 | 2017 |
| Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA A Endimiani, AM Hujer, F Perez, CR Bethel, KM Hujer, J Kroeger, ... Journal of Antimicrobial Chemotherapy 63 (3), 427-437, 2009 | 293 | 2009 |
| Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients F Perez, D Van Duin Cleveland Clinic journal of medicine 80 (4), 225, 2013 | 291 | 2013 |
| Identification of a New Allelic Variant of the Acinetobacter baumannii Cephalosporinase, ADC-7 β-Lactamase: Defining a Unique Family of Class C Enzymes KM Hujer, NS Hamza, AM Hujer, F Perez, MS Helfand, CR Bethel, ... Antimicrobial agents and chemotherapy 49 (7), 2941-2948, 2005 | 283 | 2005 |
| Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan D Marchaim, T Chopra, JM Pogue, F Perez, AM Hujer, S Rudin, ... Antimicrobial agents and chemotherapy 55 (2), 593-599, 2011 | 276 | 2011 |
| Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality LJ Rojas, M Salim, E Cober, SS Richter, F Perez, RA Salata, RC Kalayjian, ... Clinical Infectious Diseases 64 (6), 711-718, 2017 | 257 | 2017 |
| Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination F Perez, A Endimiani, AJ Ray, BK Decker, CJ Wallace, KM Hujer, ... Journal of antimicrobial Chemotherapy 65 (8), 1807-1818, 2010 | 254 | 2010 |
| In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin A Endimiani, G Patel, KM Hujer, M Swaminathan, F Perez, LB Rice, ... Antimicrobial agents and chemotherapy 54 (1), 526-529, 2010 | 211 | 2010 |
| Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments A Rodriguez Guardado, A Blanco, V Asensi, F Pérez, JC Rial, V Pintado, ... Journal of Antimicrobial Chemotherapy 61 (4), 908-913, 2008 | 204 | 2008 |
| Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods R Viau, KM Frank, MR Jacobs, B Wilson, K Kaye, CJ Donskey, F Perez, ... Clinical microbiology reviews 29 (1), 1-27, 2016 | 202 | 2016 |
| Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy? F Perez, NG El Chakhtoura, KM Papp-Wallace, BM Wilson, RA Bonomo Expert opinion on pharmacotherapy 17 (6), 761-781, 2016 | 191 | 2016 |
| New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis MS Wright, DH Haft, DM Harkins, F Perez, KM Hujer, S Bajaksouzian, ... MBio 5 (1), 10.1128/mbio. 00963-13, 2014 | 188 | 2014 |
| Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network D Van Duin, F Perez, SD Rudin, E Cober, J Hanrahan, J Ziegler, ... Antimicrobial agents and chemotherapy 58 (7), 4035-4041, 2014 | 185 | 2014 |
| Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa JM Pogue, KS Kaye, MP Veve, TS Patel, AT Gerlach, SL Davis, ... Clinical Infectious Diseases 71 (2), 304-310, 2020 | 181 | 2020 |
| A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase … B Gutiérrez-Gutiérrez, S Perez-Galera, E Salamanca, M De Cueto, ... Antimicrobial agents and chemotherapy 60 (7), 4159-4169, 2016 | 177 | 2016 |
| Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system A Endimiani, JM DePasquale, S Forero, F Perez, AM Hujer, ... Journal of antimicrobial chemotherapy 64 (5), 1102-1110, 2009 | 174 | 2009 |
Robert BonomoProfessor, Medicine, Pharmacology, Molecular and Microbiology, and BiochemistryPatvirtintas el. paštas va.gov
